Industry News
Pharmaxis inflammatory disease drug enters phase I
Pharmaxis (ASX:PXS) has kicked off a phase I single ascending dose study of PXS428A, an SSAO inhibitor with the potential to treat inflammatory diseases including non-alcoholic steatohepatitis.
[ + ]Australian immunologist wins AAI Lifetime Achievement Award
Professor Jonathan Sprent FAA FRS has been selected by the American Association of Immunologists (AAI) as the 2015 recipient of the AAI Lifetime Achievement Award. [ + ]
Australian immunologist wins AAI Lifetime Achievement Award
Professor Jonathan Sprent FAA FRS has been selected by the American Association of Immunologists (AAI) as the 2015 recipient of the AAI Lifetime Achievement Award. [ + ]
Gut bacteria may protect women against MS
Stomach ulcer bug associated with a lower risk of multiple sclerosis in women. [ + ]
Medical Developments close to Penthrox approval in UK
Medical Developments International (ASX:MVP) is close to securing approval from the UK's MHRA for its inhaled analgesic Penthrox.
[ + ]Prima appoints head of investor relations
Prima BioMed (ASX:PRR) has named Stewart Roberts its head of investor relations, as the company seeks to build on the acquisition of Immutep by attracting new shareholders.
[ + ]Tapping into axonal fusion
Molecules that act to glue severed nerves back together in roundworms may lead the way to regenerating damaged nerves. [ + ]
CEOs' views sought on consultations: share schemes and equity crowd funding
Among the proposals included in the October release of the federal government's Industry Innovation and Competitiveness Agenda (IICA) was a consultation on a potential regulatory framework for crowd-sourced equity funding (CSEF) in Australia and the tax treatment of employee share schemes (ESS), to be repaired after the 2009 changes saw companies flee the program.
[ + ]Science 50:50 to encourage more female scientists
Prominent scientist and inventor Professor Veena Sahajwalla has launched the Science 50:50 initiative - a program to inspire young women to pursue degrees and careers in the fields of STEM (science, technology, engineering and mathematics). The premise of the program is simple: since half of the population is female, why not half the scientists and technologists? [ + ]
DNA extracted from extinct giant kangaroos
South Australian scientists have succeeded in extracting DNA sequences from two species of the country's extinct kangaroos - the giant short-faced kangaroo (Simosthenurus occidentalis) and the giant wallaby (Protemnodon anak). [ + ]
Science 50:50 to encourage more female scientists
Prominent scientist and inventor Professor Veena Sahajwalla has launched the Science 50:50 initiative - a program to inspire young women to pursue degrees and careers in the fields of STEM (science, technology, engineering and mathematics). The premise of the program is simple: since half of the population is female, why not half the scientists and technologists? [ + ]
DNA extracted from extinct giant kangaroos
South Australian scientists have succeeded in extracting DNA sequences from two species of the country's extinct kangaroos - the giant short-faced kangaroo (Simosthenurus occidentalis) and the giant wallaby (Protemnodon anak). [ + ]
Orthocell wins Chinese patent for Celgro
Orthocell (ASX:OCC) has been granted a Chinese patent for its Celgro collagen bio-scaffold platform technology, augmenting its IP protection in the APAC region.
[ + ]Ethical guidelines on organ transplantation open for consultation
The National Health and Medical Research Council (MHMRC) has released a draft document to inform decisions around the allocation of organs for transplantation. [ + ]
Ethical guidelines on organ transplantation open for consultation
The National Health and Medical Research Council (NHMRC) has released a draft document to inform decisions around the allocation of organs for transplantation. [ + ]